Literature DB >> 11795898

R-alpha-lipoic acid action on cell redox status, the insulin receptor, and glucose uptake in 3T3-L1 adipocytes.

Hadi Moini1, Oren Tirosh, Young Chul Park, Kyung-Joo Cho, Lester Packer.   

Abstract

The insulin signaling pathway has been reported to mediate R-alpha-lipoic acid- (R-LA-)-stimulated glucose uptake into 3T3-L1 adipocytes and L6 myotubes. We investigated the role of the thiol antioxidant dihydrolipoic acid (DHLA) and intracellular glutathione (GSH) in R-LA-stimulated glucose transport and explored the hypothesis that R-LA could increase glucose uptake into 3T3-L1 adipocytes in an oxidant-mimetic manner. R-LA pretreatment of 3T3-L1 cells stimulated glucose transport at early time points (30 min - 6 h), whereas it inhibited glucose uptake at later time points. Analysis of the oxidized and reduced content of LA in cells and medium showed that >90% of lipoic acid present was in its oxidized form. Furthermore, all oxidized forms of LA (S-, R-, and racemic LA) stimulated glucose uptake, whereas the reduced form, dihydrolipoic acid, was ineffective. Intracellular GSH levels were not changed at the early time points (before 12 h), while longer preincubation (24 - 48 h) of cells with R-LA significantly increased intracellular GSH. Pretreatment of adipocytes with R-LA increased intracellular peroxide levels at early time points (30 min - 6 h), after which it was decreased (12 - 48 h). R-LA also increased tyrosine phosphorylation of immunoprecipitated insulin receptors from 3T3-L1 adipocytes. These results indicate that (i) 3T3-L1 adipocytes have a low capacity to reduce R-LA and the oxidized form of lipoic acid is responsible for stimulating glucose uptake, (ii) R-LA modulates glucose uptake by changing the intracellular redox status, and (iii) the insulin receptor is a potential cellular target for R-LA action. (c)2002 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11795898     DOI: 10.1006/abbi.2001.2680

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  22 in total

Review 1.  Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential.

Authors:  Kate Petersen Shay; Régis F Moreau; Eric J Smith; Anthony R Smith; Tory M Hagen
Journal:  Biochim Biophys Acta       Date:  2009-08-04

2.  α-Lipoic acid ameliorates impaired glucose uptake in LYRM1 overexpressing 3T3-L1 adipocytes through the IRS-1/Akt signaling pathway.

Authors:  Zhen-Ying Qin; Min Zhang; Xi-Rong Guo; Yu-Mei Wang; Guan-Zhong Zhu; Yu-Hui Ni; Ya-Ping Zhao; Jie Qiu; Chun-Zhao Kou; Rui Qin; Xin-Guo Cao
Journal:  J Bioenerg Biomembr       Date:  2012-07-22       Impact factor: 2.945

3.  α-Lipoic acid protects 3T3-L1 adipocytes from NYGGF4 (PID1) overexpression-induced insulin resistance through increasing phosphorylation of IRS-1 and Akt.

Authors:  Yu-mei Wang; Xiao-fei Lin; Chun-mei Shi; Lan Lu; Zhen-Ying Qin; Guan-zhong Zhu; Xin-guo Cao; Chen-bo Ji; Jie Qiu; Xi-rong Guo
Journal:  J Bioenerg Biomembr       Date:  2012-04-21       Impact factor: 2.945

4.  Crocetin attenuates palmitate-induced insulin insensitivity and disordered tumor necrosis factor-alpha and adiponectin expression in rat adipocytes.

Authors:  L Xi; Z Qian; G Xu; C Zhou; S Sun
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

5.  Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans.

Authors:  Ethan J Anderson; Mary E Lustig; Kristen E Boyle; Tracey L Woodlief; Daniel A Kane; Chien-Te Lin; Jesse W Price; Li Kang; Peter S Rabinovitch; Hazel H Szeto; Joseph A Houmard; Ronald N Cortright; David H Wasserman; P Darrell Neufer
Journal:  J Clin Invest       Date:  2009-02-02       Impact factor: 14.808

6.  Lipoic acid significantly restores, in rats, the age-related decline in vasomotion.

Authors:  A R Smith; F Visioli; B Frei; T M Hagen
Journal:  Br J Pharmacol       Date:  2008-02-25       Impact factor: 8.739

Review 7.  The energy-redox axis in aging and age-related neurodegeneration.

Authors:  Li-Peng Yap; Jerome V Garcia; Derick Han; Enrique Cadenas
Journal:  Adv Drug Deliv Rev       Date:  2009-08-27       Impact factor: 15.470

8.  Adverse cardiac responses to alpha-lipoic acid in a rat-diabetic model: possible mechanisms?

Authors:  Nouf M Al-Rasheed; Nawal M Al-Rasheed; Hala A Attia; Iman H Hasan; Maha Al-Amin; Hanaa Al-Ajmi; Raeesa A Mohamad
Journal:  J Physiol Biochem       Date:  2013-04-18       Impact factor: 4.158

Review 9.  Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential.

Authors:  Daniele Tibullo; Giovanni Li Volti; Cesarina Giallongo; Sonia Grasso; Daniele Tomassoni; Carmelina Daniela Anfuso; Gabriella Lupo; Francesco Amenta; Roberto Avola; Vincenzo Bramanti
Journal:  Inflamm Res       Date:  2017-07-04       Impact factor: 4.575

10.  Lipoic acid inhibits adiponectin production in 3T3-L1 adipocytes.

Authors:  Pedro L Prieto-Hontoria; Marta Fernández-Galilea; Patricia Pérez-Matute; J Alfredo Martínez; María J Moreno-Aliaga
Journal:  J Physiol Biochem       Date:  2013-01-12       Impact factor: 4.158

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.